E Shroom, 17 Fledgling Psychedelic Stocks To Watch Going Forward

Editors' note: This article discusses one or more penny stocks and/or microcaps. Such stocks are easily manipulated; do your own careful due diligence.


image source

The small-cap markets have been invaded with a flurry of new psychedelic stocks to watch thanks to new company launches. Investors now have a variety of options for taking a run in the "shroom" stocks space and for researching psychedelic medicine.

More and more companies are starting to investigate the potential of psychedelic mushrooms as an innovative way to treat mental health issues and are looking to raise capital in the public market. This has attracted the interest of savvy investors as these psychedelic stocks offer an emerging investment opportunity.

The munKNEE Pure-Play Psychedelic Stocks Index consists of 11 bio-pharmaceutical publicly-traded psychedelic stocks but there are 9 other companies entering the sector that a) have less than $50M market caps (average $19.9M) and b) trade for less than $1.00/share (average of $0.04/share) and they are worth keeping on the radar as this fledgling, but burgeoning, sector develops, expands and prospers.

The psychedelics stocks to watch are, in alphabetical order:

1 2 3 4
View single page >> |

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample  more

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.